The trading price of Catheter Precision Inc (AMEX:VTAK) closed lower on Tuesday, May 27, and closing at $0.19, -21.76% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $8.40 and a 52-week low of $0.20. Over the past month, the stock has lost -35.23% in value.
Catheter Precision Inc, whose market valuation is $2.07 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest VTAK has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that VTAK’s price is currently -31.44% off the SMA20 and -40.16% off the SMA50. The RSI metric on the 14-day chart is currently showing 32.41, and weekly volatility stands at 24.24%. When measured over the past 30 days, the indicator reaches 11.05%. Catheter Precision Inc (AMEX:VTAK)’s beta value is currently sitting at -0.79, while the Average True Range indicator is currently displaying 0.04.
To see how Catheter Precision Inc stock has been performing in comparison to its peers in the industry, here are the numbers: VTAK stock’s performance was -21.76% in the latest trading, and -96.57% in the past year.
An evaluation of the daily trading volume of Catheter Precision Inc (AMEX:VTAK) indicates that the 3-month average is 438.54K.
Currently, records show that 11.02 million of the company’s shares remain outstanding. The insiders hold 6.33% of outstanding shares, whereas institutions hold 5.34%. However, since the stock’s price has seen -58.38% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
